KUALA LUMPUR: Bintai Kinden Corporation Bhd’s subsidiary has picked ASX-listed IEC Properties Pty Ltd as sole distributor for the Ii-Key-SARS-CoV-2 Covid-19 vaccine in Australia and New Zealand.
Bintai Healthcare Sdn Bhd had on Thursday signed an MoU with IEC – a unit of International Equities Corporation Ltd to further negotiate on the terms and conditions to grant IEC the exclusive distribution rights.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!